Martin Pulé
69Patents
5h-index
47Co-inventors
68Inventor score
Filing activity: Apr 11, 2013 → May 24, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10172885B2 | Cell | Chemistry; Metallurgy | 16 | Active |
| US10172886B2 | Cell | Chemistry; Metallurgy | 12 | Active |
| US10730942B2 | Protein-based T-cell receptor knockdown | Chemistry; Metallurgy | 11 | Active |
| US10457730B2 | Chimeric antigen receptor (CAR) comprising a CD19-binding domain | Chemistry; Metallurgy | 10 | Active |
| US10098926B2 | Cell | Chemistry; Metallurgy | 9 | Active |
| US10800854B2 | Chimeric cytokine receptors and encoding nucleic acids | Chemistry; Metallurgy | 5 | Active |
| US11034750B2 | Chimeric antigen receptor (CAR) comprising a CD19-binding domain | Chemistry; Metallurgy | 4 | Active |
| US11091532B2 | T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor | Chemistry; Metallurgy | 4 | Active |
| US10098911B2 | Chimeric protein | Emerging Cross-Sectional Technologies | 4 | Active |
| US10800855B2 | Chimeric cytokine receptors and encoding nucleic acids | Chemistry; Metallurgy | 4 | Active |
| US10174099B2 | Cell | Chemistry; Metallurgy | 4 | Active |
| US10981970B2 | Chimeric antigen receptor (CAR) comprising a CD22-binding domain | Chemistry; Metallurgy | 4 | Active |
| US10160794B2 | Chimeric antigen receptor | Human Necessities | 3 | Active |
| US11180553B2 | Chimeric antigen receptor | Chemistry; Metallurgy | 3 | Active |
| US10478457B2 | Chimeric protein | Emerging Cross-Sectional Technologies | 2 | Active |
| US11365262B2 | Cell | Chemistry; Metallurgy | 2 | Active |
| US10925943B2 | Marker-suicide gene useful in adoptive cell therapy | Chemistry; Metallurgy | 2 | Active |
| US11590170B2 | Chimeric antigen receptor | Chemistry; Metallurgy | 2 | Active |
| US11058722B2 | Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-coil spacer domain | Chemistry; Metallurgy | 2 | Active |
| US11479613B2 | Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins | Chemistry; Metallurgy | 1 | Active |
| US11701386B2 | Cell | Chemistry; Metallurgy | 1 | Active |
| US11851672B2 | CAR T-cells comprising transcriptional circuits | Chemistry; Metallurgy | 1 | Active |
| US10745715B2 | Method and means for purifying retroviral vectors | Chemistry; Metallurgy | 1 | Active |
| US10611811B2 | Ligand | Physics | 1 | Active |
| US11345734B2 | Chimeric T cell | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.